Gene One Life Science postpones extraordinary shareholders meeting to Nov. 30
Gene One Life Science revised its shareholder-meeting call, pushing the extraordinary meeting to Nov. 30, 2026 from Oct. 30. The voting record date shifted to Oct. 28, 2026 from Oct. 2. * Agenda scope expanded to include a proposed revision to executive retirement-benefit rules, alongside planned charter and board-rela